Brainstorm Cell Therapeutics Received Letter From Nasdaq Indicating Co Had Not Regained Compliance With Minimum Bid Price Requirement By April 29
Brainstorm Cell Therapeutics Received Letter From Nasdaq Indicating Co Had Not Regained Compliance With Minimum Bid Price Requirement By April 29
Brainstorm Cell Therapeutics收到納斯達克的來信，表明該公司在4月29日之前尚未恢復對最低出價要求的遵守
Brainstorm Cell Therapeutics Received Letter From Nasdaq Indicating Co Had Not Regained Compliance With Minimum Bid Price Requirement By April 29
Brainstorm Cell Therapeutics收到納斯達克的來信，表明該公司在4月29日之前尚未恢復對最低出價要求的遵守
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。